CI

At a glance

ClinicalIndex Comparison Record
N/ACompleted· 420 enrolled
Drug / intervention
WHTother
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.

Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.

Search/NCT03299556
NCT03299556N/ACompleted

Effect of Wearable Health Technology on Patients Treated for Chronic Pain at Geisinger Health System

Purdue Pharma LP·observational·Posted Oct 3, 2017·Updated Sep 19, 2024

In Brief

An observational study evaluating WHT for Chronic Pain. Completed, enrolled 420 participants across 1 site.

Detailed Summary

This is a proof of concept study to measure the effect of Wearable Health Technology (WHT), including the Apple Watch, iPhone, Pain App and Provider Dashboards on important clinical outcomes in patients treated for chronic pain. WHT will be tested in a group of chronic pain patients treated at a specialty pain clinic, the Geisinger Multidisciplinary Pain Program (MPP). Primary and secondary outcomes include pain, physical function, depression, pain medicine use, amount of sleep, activity levels, healthcare resource utilization and cost. The WHT will collect self-reported data on pain, pain management therapies, and medication utilization, and passively collected data on subject activity levels and sleep. Additional data will be collected on device utilization by patients and health care professionals.

Study Details

Study Typeobservational
Allocation--
Masking--
Primary Purpose--
ConditionsChronic Pain
CountriesUnited States
CollaboratorsGeisinger Clinic

Timeline

N/ACompletedFinished
201820192020202120222023202420252026
First PostedOct 3, 2017
Enrollment StartOct 5, 2017
Primary CompletionNov 30, 2019
TodayJul 2, 2026
Enrollment to primary: 2.2 yearsPosted 8.7 years ago

Interventions

WHTother

Incorporating WHT into treatment for chronic pain. WHT includes patient and provider tracking of patient-reported pain, pain management, medication usage, functionality, depression, activity and sleep (measured by 3 axis actigraph); as well as prompts to subjects to engage in self-care, including non-pharmaceutical pain management therapies consistent with MPP training.